DE60227278D1 - Pharmazeutische zubereitungen für die behandlung von läsionen der haut und schleimhäute und diese verwendende verfahren und kits - Google Patents

Pharmazeutische zubereitungen für die behandlung von läsionen der haut und schleimhäute und diese verwendende verfahren und kits

Info

Publication number
DE60227278D1
DE60227278D1 DE60227278T DE60227278T DE60227278D1 DE 60227278 D1 DE60227278 D1 DE 60227278D1 DE 60227278 T DE60227278 T DE 60227278T DE 60227278 T DE60227278 T DE 60227278T DE 60227278 D1 DE60227278 D1 DE 60227278D1
Authority
DE
Germany
Prior art keywords
skin
lesions
kits
mice
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60227278T
Other languages
English (en)
Inventor
Pinchas Burstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innovative Pharmaceutical Concepts IPC Inc
Original Assignee
Innovative Pharmaceutical Concepts IPC Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovative Pharmaceutical Concepts IPC Inc filed Critical Innovative Pharmaceutical Concepts IPC Inc
Application granted granted Critical
Publication of DE60227278D1 publication Critical patent/DE60227278D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60227278T 2001-10-03 2002-10-02 Pharmazeutische zubereitungen für die behandlung von läsionen der haut und schleimhäute und diese verwendende verfahren und kits Expired - Lifetime DE60227278D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/968,771 US7128903B2 (en) 2001-10-03 2001-10-03 Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
PCT/IL2002/000804 WO2003028623A2 (en) 2001-10-03 2002-10-02 Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucuous membranes

Publications (1)

Publication Number Publication Date
DE60227278D1 true DE60227278D1 (de) 2008-08-07

Family

ID=25514753

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60227278T Expired - Lifetime DE60227278D1 (de) 2001-10-03 2002-10-02 Pharmazeutische zubereitungen für die behandlung von läsionen der haut und schleimhäute und diese verwendende verfahren und kits

Country Status (9)

Country Link
US (3) US7128903B2 (de)
EP (1) EP1450771B1 (de)
AT (1) ATE399002T1 (de)
AU (1) AU2002341366A1 (de)
DE (1) DE60227278D1 (de)
DK (1) DK1450771T3 (de)
ES (1) ES2309205T3 (de)
IL (1) IL161177A0 (de)
WO (1) WO2003028623A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7128903B2 (en) 2001-10-03 2006-10-31 Innovative Pharmaceutical Concepts (Ipc) Inc. Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
US20050020693A1 (en) * 2003-07-24 2005-01-27 Richard Strauss Pharmaceutical preparations useful as drying agents and for treatment of warts
AU2004200891B2 (en) * 2004-03-01 2010-10-14 Universal Entertainment Corporation Gaming machine
GB0426308D0 (en) * 2004-12-01 2004-12-29 Byotrol Llc Preservative and embalming fluids
SE527996C2 (sv) * 2004-12-21 2006-08-01 Tagaway Devices Aps Anordning för avlägsnande av acrochordons
US8258181B2 (en) * 2005-03-23 2012-09-04 Florida Atlantic University Treatment or prevention of cancer and precancerous disorders
US8357720B2 (en) * 2005-03-23 2013-01-22 Florida Atlantic University Treatment or prevention of cancer and precancerous disorders
US8765808B2 (en) * 2005-03-23 2014-07-01 Chs Pharma, Inc. Treatment or prevention of cancer and precancerous disorders
ITRM20060289A1 (it) * 2006-05-31 2007-12-01 Ranieri Cancedda Bio membrana ingegnerizzata osteo angiogenica e suoi usi per la rigenerazione di tessuto osseo
CN101138568A (zh) * 2006-09-08 2008-03-12 刘智仁 盐酸在制备治疗糖尿病和前列腺疾病药物中的应用
WO2008052189A2 (en) * 2006-10-26 2008-05-02 Reliant Technologies, Inc. Micropore delivery of active substances
US20090269390A1 (en) * 2008-04-25 2009-10-29 Medtronic, Inc. Medical devices, polymers, compositions, and methods for delivering a haloacetate
WO2010033408A1 (en) 2008-09-17 2010-03-25 Mcgrath Patrick D Antimicrobial sucralfate paste methods and compositions
EP2363136A1 (de) * 2010-03-02 2011-09-07 Fresenius Medical Care Deutschland GmbH Von Erwachsenenstammzellen abgeleitete Mikrovesikel zur Verwendung bei der therapeutischen Behandlung von Tumorkrankheiten
US20110218552A1 (en) * 2010-03-04 2011-09-08 Hoffman Roger P System and method of removing skin lesions
RU2482856C2 (ru) 2011-08-05 2013-05-27 Общество С Ограниченной Ответственностью "Оксигон" Комплексное соединение 2-хлорпропионата цинка и 2-хлорпропионовой кислоты, фармацевтическая композиция для лечения заболеваний кожи, способ ее получения и способ лечения поражений кожи, ногтей и видимых слизистых
ES2795448T3 (es) * 2012-09-19 2020-11-23 Innovative Pharmaceutical Concepts Ipc Inc Aplicador médico
US9987235B2 (en) * 2013-08-01 2018-06-05 Nicholas L. Abbott Methods and compositions for modifying mucous membranes
US10588564B2 (en) * 2014-09-30 2020-03-17 Moein Health, LLC Method and kit for diagnosing and treating neoplastic tissue
NL2014370B1 (nl) 2015-02-27 2017-01-17 Versailles B V Inrichting en werkwijze voor het aanbrengen van een samenstelling aan de huid of huidlagen.
ES2769673A1 (es) * 2018-12-20 2020-06-26 Philippe Deprez Composición a base de fenol y sus usos

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195095A (en) * 1969-04-04 1980-03-25 Sheffner Aaron L Topical application of thioglycolic acid in the treatment of dermatological conditions
US3924623A (en) * 1974-11-04 1975-12-09 Marion Health And Safety Inc Tip for applicator swab
CH629100A5 (de) 1979-09-27 1982-04-15 Solco Basel Ag Hautpraeparat.
DE3035069C1 (de) * 1980-09-17 1982-05-27 Zyma Gmbh Saures dermatologisches Praeparat
US4588590A (en) * 1981-12-21 1986-05-13 Jaye-Boern Laboratories, Inc. Method of treating keratosis and compositions useful therefor
US5547988B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Alleviating signs of dermatological aging with glycolic acid lactic acid or citric acid
US5385938B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of using glycolic acid for treating wrinkles
US5166176A (en) * 1986-12-29 1992-11-24 Obagi Zein E Composition for healing damaged skin
US5276032A (en) * 1989-12-28 1994-01-04 King O Newton Vision aid and anesthetic composition
US5322856A (en) * 1990-01-22 1994-06-21 Howard Martin Fortified glutaraldehyde chemical sterilant/disinfectant
TW210287B (de) * 1991-03-01 1993-08-01 Kabushikaisha Ueno Seiyaku Oyo Kenkyujo
EP0627879A1 (de) * 1991-09-20 1994-12-14 CAMIENER, Gerald, W. Verfahren und zusammensetzungen mit einer aldehydstabilisierenden lösung
MY128187A (en) 1993-06-23 2007-01-31 Icn Switzerland Ag Preparation for skin and mucous membrane
US5874463A (en) * 1994-10-24 1999-02-23 Ancira; Margaret Hydroxy-kojic acid skin peel
JP3595012B2 (ja) 1995-02-07 2004-12-02 第一製網株式会社 養殖海苔の赤腐れ病駆除剤
US5700656A (en) * 1995-05-25 1997-12-23 Pig Research Institute, Taiwan Silver stain for collagen matrix from paraffin embedded tissue
UY24246A1 (es) * 1995-06-06 1996-06-14 Neutrogena Corp Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado
CN1059228C (zh) * 1995-10-11 2000-12-06 范暄民 消毒护肤洗手净
US5791801A (en) * 1996-08-30 1998-08-11 Siebe North, Inc. Liquid applicator
WO1998017247A1 (en) * 1996-10-23 1998-04-30 The Procter & Gamble Company Aqueous topical compositions comprising kojic acid, salicylic acid and a water soluble glycol ether
US6235474B1 (en) * 1996-12-30 2001-05-22 The Johns Hopkins University Methods and kits for diagnosing and determination of the predisposition for diseases
GB9807287D0 (en) * 1998-04-03 1998-06-03 Verdugt Bv Biocidal compositions
FR2782269B1 (fr) * 1998-08-17 2001-08-31 Oreal Composition cosmetique et/ou dermatologique contenant de l'acide salicylique ou un derive d'acide salicylique et son utilisation
US6573043B1 (en) * 1998-10-07 2003-06-03 Genentech, Inc. Tissue analysis and kits therefor
SE513436C2 (sv) * 1999-01-21 2000-09-11 Astrid Agholme Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus
FR2792642B1 (fr) * 1999-04-21 2001-06-08 Oreal Composition cosmetique contenant des particules de resine de melamine-formaldehyde ou d'uree-formaldehyde et ses utilisations
IT1312313B1 (it) * 1999-05-24 2002-04-15 Giorgio Mezzoli Acido tricloroacetico per la preparazione di soluzioni e/ocomposizioni per il trattamento di lesioni erosive e/o ulcerative.
IT1306171B1 (it) * 1999-07-21 2001-05-30 Wiktor Djaczenko Composizione farmaceutica a base di c2 hcl3o2, un polimero h (och2ch2)6oh, acido 2-idrossibenzoico, (1alfa, 2beta, 5alfa) -5-metil-2-
US6391860B1 (en) * 1999-09-09 2002-05-21 Mcgrath Patrick D. Method for preparation and use of paste formed by controlled reaction of sucralfate with hydrochloric acid
CN1273827A (zh) * 2000-04-24 2000-11-22 潘志荣 一种除癣灭痔杀菌液
US20040198819A1 (en) 2001-06-20 2004-10-07 Young Aiping H. Biological response modifier composition and uses thereof
US7128903B2 (en) * 2001-10-03 2006-10-31 Innovative Pharmaceutical Concepts (Ipc) Inc. Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same

Also Published As

Publication number Publication date
IL161177A0 (en) 2004-08-31
ATE399002T1 (de) 2008-07-15
EP1450771B1 (de) 2008-06-25
EP1450771A4 (de) 2005-04-27
DK1450771T3 (da) 2008-10-06
US20090123568A1 (en) 2009-05-14
EP1450771A2 (de) 2004-09-01
US7128903B2 (en) 2006-10-31
WO2003028623A3 (en) 2004-03-18
US20030087960A1 (en) 2003-05-08
ES2309205T3 (es) 2008-12-16
US8658185B2 (en) 2014-02-25
WO2003028623A2 (en) 2003-04-10
AU2002341366A1 (en) 2003-04-14
US20040234625A1 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
DE60227278D1 (de) Pharmazeutische zubereitungen für die behandlung von läsionen der haut und schleimhäute und diese verwendende verfahren und kits
ATE241365T1 (de) Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen
MXPA05006940A (es) Formulaciones terapeuticas para el tratamiento de enfermedades relacionadas con beta - amiloide.
ATE314092T1 (de) Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen
HUP0102899A2 (hu) Eljárás gyulladásgátló, különösen fertőtlenítő hatású és/vagy sebgyógyulást elősegítő szerek alsó légutakba történő beadására szolgáló készítmények előállítására
DE60236413D1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
SE9704833D0 (sv) New formulation
DE60137635D1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
DE69116380T2 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
ATE515253T1 (de) Zusammensetzungen auf basis von etyllinoleat und triethylcitrat zur behandlung von seborrhöe und akne
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
ATE336997T1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
RU2106154C1 (ru) Перевязочный материал
EE9900428A (et) Köhavastased ravimkoostised
HUP0100012A2 (hu) Makrolid vegyületek alkalmazása rák és a makuláns elváltozások kezelésére
SE9803761D0 (sv) Method to avoid increased iridial pigmentation during prostaglandin treatment
DK1343472T3 (da) Thixotropisk næsespray
DE60005952D1 (de) Löslische hla-g enthaltende zusammensetsungen zur behandlung entzündlichen hautkrankheiten
JPH0838173A (ja) 壊死組織を処理するための新規なプロテアーゼ
ATE311897T1 (de) Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone
ATE258229T1 (de) Substanz fa-70d, herstellungsverfahren und verwendungen
BG105924A (en) Composition for the treatment of psoriasis
ATE203680T1 (de) Konjugat zur behandlung von entzündungserkrankungen
DE60202446D1 (de) Pharmazeutische formulierung und ihre verwendung für die herstellung eines medikaments zur behandlung von herz-kreislauf-erkrankungen
US4250167A (en) Methods for reducing calcium deposits

Legal Events

Date Code Title Description
8364 No opposition during term of opposition